Ocugen (OCGN) Current Deferred Revenue (2014 - 2018)
Ocugen's (OCGN) quarterly Current Deferred Revenue came in at $45000.0 in Q4 2018, up 28.57% YoY from $35000.0 in Q4 2017, and down 99.1% on a QoQ basis from $5.0 million in Q3 2018.
Analysis
Ocugen (OCGN) Current Deferred Revenue (2014 - 2018) Analysis & Trends
Ocugen (OCGN) has 5 years of Current Deferred Revenue data on file, last reported at $45000.0 in Q4 2018.
- Quarterly Current Deferred Revenue rose 28.57% year-over-year to $45000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $45000.0 (up 28.57% YoY) and the FY2018 annual result came in at $45000.0, up 28.57% from the prior year.
- Current Deferred Revenue declined to $45000.0 in Q4 2018, from $5.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $7.5 million in Q2 2018 to a low of $35000.0 in Q4 2017.
- A 5-year average of $1.1 million and a median of $133000.0 in 2016 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2017 — Current Deferred Revenue tumbled 74.26% — and 2018, when it jumped 8620.93%.
- Tracing OCGN's Current Deferred Revenue over 5 years: stood at $219000.0 in 2014, then tumbled by 42.47% to $126000.0 in 2015, then rose by 7.94% to $136000.0 in 2016, then plunged by 74.26% to $35000.0 in 2017, then gained by 28.57% to $45000.0 in 2018.
- The last three Current Deferred Revenue figures came in at $45000.0 (Q4 2018), $5.0 million (Q3 2018), and $7.5 million (Q2 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 45,000.00 |
| Sep 30, 2018 | 5.00 Mn |
| Jun 30, 2018 | 7.50 Mn |
| Mar 31, 2018 | 5.00 Mn |
| Dec 31, 2017 | 35,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 86,000.00 |
| Mar 31, 2017 | 110,000.00 |
| Dec 31, 2016 | 136,000.00 |
| Sep 30, 2016 | 133,000.00 |
| Jun 30, 2016 | 131,000.00 |
| Mar 31, 2016 | 128,000.00 |
| Dec 31, 2015 | 126,000.00 |
| Sep 30, 2015 | 225,000.00 |
| Jun 30, 2015 | 223,000.00 |
| Mar 31, 2015 | 224,000.00 |
| Dec 31, 2014 | 219,000.00 |